Literature DB >> 28512241

Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity.

Johanna Holm1, Louise Eriksson2,3, Alexander Ploner2, Mikael Eriksson2, Mattias Rantalainen2, Jingmei Li2, Per Hall2,4, Kamila Czene2.   

Abstract

Subtype heterogeneity for breast cancer risk factors has been suspected, potentially reflecting etiologic differences and implicating risk prediction. However, reports are conflicting regarding the presence of heterogeneity for many exposures. To examine subtype heterogeneity across known breast cancer risk factors, we conducted a case-control analysis of 2,632 breast cancers and 15,945 controls in Sweden. Molecular subtype was predicted from pathology record-derived IHC markers by a classifier trained on PAM50 subtyping. Multinomial logistic regression estimated separate ORs for each subtype by the exposures parity, age at first birth, breastfeeding, menarche, hormone replacement therapy use, somatotype at age 18, benign breast disease, mammographic density, polygenic risk score, family history of breast cancer, and BRCA mutations. We found clear subtype heterogeneity for genetic factors and breastfeeding. Polygenic risk score was associated with all subtypes except for the basal-like (Pheterogeneity < 0.0001). "Never breastfeeding" was associated with increased risk of basal-like subtype [OR 4.17; 95% confidence interval (CI) 1.89-9.21] compared with both nulliparity (reference) and breastfeeding. Breastfeeding was not associated with risk of HER2-overexpressing type, but protective for all other subtypes. The observed heterogeneity in risk of distinct breast cancer subtypes for germline variants supports heterogeneity in etiology and has implications for their use in risk prediction. The association between basal-like subtype and breastfeeding merits more research into potential causal mechanisms and confounders. Cancer Res; 77(13); 3708-17. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 28512241     DOI: 10.1158/0008-5472.CAN-16-2574

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis.

Authors:  He Shen; Nuo Yang; Alexander Truskinovsky; Yanmin Chen; Ashley L Mussell; Norma J Nowak; Lester Kobzik; Costa Frangou; Jianmin Zhang
Journal:  Mol Cancer Res       Date:  2018-09-20       Impact factor: 5.852

2.  Assessing multiparametric drug response in tissue engineered tumor microenvironment models.

Authors:  Alexandra R Harris; Jessica X Yuan; Jennifer M Munson
Journal:  Methods       Date:  2017-12-16       Impact factor: 3.608

Review 3.  A causal mechanism for childhood acute lymphoblastic leukaemia.

Authors:  Mel Greaves
Journal:  Nat Rev Cancer       Date:  2018-08       Impact factor: 60.716

4.  Evidence for Etiologic Subtypes of Breast Cancer in the Carolina Breast Cancer Study.

Authors:  Halei C Benefield; Emily C Zabor; Yue Shan; Emma H Allott; Colin B Begg; Melissa A Troester
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-08-08       Impact factor: 4.254

5.  Association of mammographic density measures and breast cancer "intrinsic" molecular subtypes.

Authors:  Geffen Kleinstern; Christopher G Scott; Rulla M Tamimi; Matthew R Jensen; V Shane Pankratz; Kimberly A Bertrand; Aaron D Norman; Daniel W Visscher; Fergus J Couch; Kathleen Brandt; John Shepherd; Fang-Fang Wu; Yunn-Yi Chen; Steven R Cummings; Stacey Winham; Karla Kerlikowske; Celine M Vachon
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

6.  Associations between mammographic density and tumor characteristics in Chinese women with breast cancer.

Authors:  Erni Li; Jennifer L Guida; Yuan Tian; Hyuna Sung; Hela Koka; Mengjie Li; Ariane Chan; Han Zhang; Eric Tang; Changyuan Guo; Joseph Deng; Nan Hu; Ning Lu; Gretchen L Gierach; Jing Li; Xiaohong R Yang
Journal:  Breast Cancer Res Treat       Date:  2019-06-28       Impact factor: 4.872

7.  Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.

Authors:  Katie M Marker; Valentina A Zavala; Tatiana Vidaurre; Paul C Lott; Jeannie Navarro Vásquez; Sandro Casavilca-Zambrano; Mónica Calderón; Julio E Abugattas; Henry L Gómez; Hugo A Fuentes; Ruddy Liendo Picoaga; Jose M Cotrina; Silvia P Neciosup; Carlos A Castañeda; Zaida Morante; Fernando Valencia; Javier Torres; Magdalena Echeverry; Mabel E Bohórquez; Guadalupe Polanco-Echeverry; Ana P Estrada-Florez; Silvia J Serrano-Gómez; Jenny A Carmona-Valencia; Isabel Alvarado-Cabrero; María Carolina Sanabria-Salas; Alejandro Velez; Jorge Donado; Sikai Song; Daniel Cherry; Lizeth I Tamayo; Scott Huntsman; Donglei Hu; Roberto Ruiz-Cordero; Ronald Balassanian; Elad Ziv; Jovanny Zabaleta; Luis Carvajal-Carmona; Laura Fejerman
Journal:  Cancer Res       Date:  2020-04-03       Impact factor: 12.701

8.  Pro-inflammatory cytokines and growth factors in human milk: an exploratory analysis of racial differences to inform breast cancer etiology.

Authors:  Jeanne Murphy; Ruth M Pfeiffer; Brittny C Davis Lynn; Ana I Caballero; Eva P Browne; Elizabeth C Punska; Hannah P Yang; Roni T Falk; Douglas L Anderton; Gretchen L Gierach; Kathleen F Arcaro; Mark E Sherman
Journal:  Breast Cancer Res Treat       Date:  2018-08-06       Impact factor: 4.872

9.  Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype.

Authors:  Mia M Gaudet; Gretchen L Gierach; Brian D Carter; Juhua Luo; Roger L Milne; Elisabete Weiderpass; Graham G Giles; Rulla M Tamimi; A Heather Eliassen; Bernard Rosner; Alicja Wolk; Hans-Olov Adami; Karen L Margolis; Susan M Gapstur; Montserrat Garcia-Closas; Louise A Brinton
Journal:  Cancer Res       Date:  2018-09-05       Impact factor: 12.701

10.  Risk factors for breast cancer subtypes among Black women undergoing screening mammography.

Authors:  Tara M Friebel-Klingner; Sarah Ehsan; Emily F Conant; Despina Kontos; Susan M Domchek; Anne Marie McCarthy
Journal:  Breast Cancer Res Treat       Date:  2021-08-03       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.